chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dizziness several minutes after injection; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 06Apr2021 at 16:30 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, type 2 diabetes mellitus, function liver abnormal and carotid artery disease. The patient previously took ciprofloxacin on an unknown date for unknown indication and experienced allergy. The patient did received medication within two weeks of vaccination which are not specified. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 several minutes after injection the patient experienced dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event dizziness was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
RN was getting ready to administer the COVID vaccine to the pt but thought clerk said she was ready for RN to administer the vaccine. pt came in and states she had an apt at 1130 but apt was actually at 1330. After RN administered the Pfizer COVID vaccine, RN learned that pt actually received the Moderna Vaccine on 5/19/21. Dose administered today was for Pfizer. Pt remained in clinic x30 mins. No reactions were noted. Pt was aware that she received the incorrect vaccine today. Spoke to charge RN regarding this error.
11-15-10 - patient called & complained that since she had shot last month - her arm is still sore/painful - hard to lift arm without pain - sometimes radiating down to elbow.
4 pts recvd 3 doses of Engerix-B & 2 pts JUN92, 2 pts JUL92 had neg titer; nonresponder;
Information has been received from a registered pharmacist concerning an over 60 year old female patient who a week ago, on approximately 31-AUG-2010 was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (Merck). After receiving the vaccine the injection site became red right away and then a rash developed at the injection site. At the time of the report the patient had not recovered. Patient sought unspecified medical attention. No further information is available.
pt says she had severe pain in the muscle unable to lift arm and put on shirt. did not go to er did not start treatment till 2/6/2019 per pt
pt recv vax 17OCT96 & & 31OCT96 pt devel welts @ the site, itching which spread to back by the next day;tx w/DPH;1NOV96 welts, sore joints, & swelling of the lt index finger was reported;pt seen by LMD;recovered;
A rash 3x5 inch red rash in the left arm about 3 inches below the injection site.; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EN6203), via an unspecified route of administration, administered in left arm on 24Feb2021 11:15 (at the age of 66-years-old) as dose 2, single for COVID-19 immunization. Medical history included hypertension, cholesterol, and known allergies to latex. Prior to vaccination, the patient was not pregnant, did not have COVID, and did not receive other vaccines within four weeks. Post-vaccination, the patient has not been tested for COVID-19. Concomitant medications included rosuvastatin calcium (CRESTOR); carvedilol (COREG); fish oil; and acetylsalicylic acid (ASPRIN); all taken for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of BNT162B2 (lot number: EL9269) administered in the left arm on 03Feb2021 12:30 for COVID-19 immunization. The patient experienced a rash 3x5 inch red rash in the left arm about 3 inches below the injection site on 27Feb2021 17:00. No treatment was received for the event. Outcome of the event was recovering.    No follow-up attempts are possible. No further information is expected.
2 days  experienced shortness of breath went to the doctors and had an enlarged heart,  along with a mass near her lungs
Information has been received from a registered nurse concerning a female patient in her early 20's who in May 2007, was vaccinated IM with a first dose of Gardasil. A week later, the patient developed a rash. The patient went to see a dermatologist. It was reported that the rash was still not resolved. It was reported that the patient will not receive anymore doses of Gardasil. No product quality complaint was involved. Additional information has been requested.
Patient received the vaccine on 3-31-21.  Then at 4:00 am on 4-1-2021, he became lightheaded and reports passing out.  He had several weeks of general malaise and mild headache.  He does not recall head trauma and had no bruising, "goose egg", etc.  He felt generally unwell with a mild headache since then.  Then on May 16th, 2021, while traveling with his wife, his left hand and arm and left side of tongue became numb and week.  He was mildly confused.  His wife took him to the ER and he was transferred to hospital for neurosurgery admission. Hospital records note that they presume the subdural bleed was triggered from the fall the morning of May 5th.
Report 2002001333-1 describes sore arms in a 65 year old male who received hepatitis B vaccine recombinant (Engerix-B). Concurrent medications were not specified. The vaccinee had no major illnesses and no known allergies. On an unspecified date, the vaccinee received his first injection of hepatitis A vaccine inactivated. In July 2001, the vaccinee received injections of inactivated poliomyelitis virus vaccine and typhoid vaccine. In June 2001, and in July 2001, the vaccinee received his first and second injections of Engerix B, respectively. It was reported that in October 2001, he underwent a routine physical at a tertiary care center. An unspecified clotting study was performed. The vaccinee reported that the clotting study showed prolonged clotting in one arm, but that the other arm was normal. To the nurse practitioner's understanding, the test was repeated and the results then were normal. An electrophoresis was performed that showed an immunoglobulin G spike. The electrophoresis value was 2.3 dL on 10/1/01. On 1/18/02, the vaccinee received his third dose of Engerix B. He received two injections of the 10mcg pediatric formulation, to provide the adult dose of 20mcg. On that date, he also received his second injection of Havrix. On 1/21/02, the vaccinee developed a moderate-size hematoma at the Havrix injection site. The reporter stated that the hematoma was possibly related to Havrix. The vaccinee also complained of sore arms, tiredness, and vague myalgia; the exact onset of these symptoms was unknown. As of 2/22/02, the outcomes of the myalgia, sore arms, and tiredness were unknown. The outcome of the immunoglobulin G spike was not reported.
Injection site pain and swelling started 6 hours after booster. 25 hours (2 pm) after receiving the booster I started having severe muscle aches, fatigue (the "I got hit by a large truck" feeling). By 6 pm the aches were worsening, by 8 pm I started having  nausea & chills and couldn't warm up. By 11 pm I had a fever of 100.5. The chills turned into sweating. The fever abated by 6 am and  Lymph nodes in left arm pit are now swollen and painful. The sweating /chills continued into the next day (day2 after Booster). Today is day 2.
This spontaneous report was received from a healthcare worker (certified medical assistant) refers to multiple unspecified patients of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date in 2015 (also reported as unspecified dates ranging from 01-SEP-2015 through 29-OCT-2015), the patients were vaccinated with improperly stored VARIVAX (Merck) injection, lot # K005428, expiry date 15-APR-2016, (dose and route of administration not reported). No adverse effects reported. No product quality complaint (PQC) was involved. No further information provided. Additional information has been requested.
11/30/01, pt given DTaP, HIB, HBV, IPV, Prenvar. 01/29/02, pt given immunizations as above, on 01/20/2002 had poss. febrile seizure. On 04/01/02, pt givne HIB vacine only, 04/03/02, had seizure activity in AM. Fever with sz.
tested positive for covid; tested positive for covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Feb2021 as dose 1, single (Lot number: EN5318), in right arm, on 18Feb2021 as dose 2, single (Lot number: EN6201), in left arm, on 03Dec2021 as dose 3 (booster), single (Lot number: FH8030), in left arm and on 04Apr2022 as dose 4 (booster), single (Lot number: FJ9943) at the age of 63 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: OMEPRAZOLE. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 18Apr2022, outcome "not recovered" and all described as "tested positive for covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: I did a home test and it was a strong positive; (unspecified date) Positive, notes: I had a PCR on 31Apr2022 that confirmed positive; (18Apr2022) Positive, notes: tested positive for Covid on 18Apr which was confirmed with a PCR test; (24Apr2022) Negative, notes: I did a rapid test and was negative. Therapeutic measures were taken as a result of drug ineffective, covid-19. Patient tested positive for Covid on 18Apr which was confirmed with a PCR test. She started Paxlovid the evening of 19Apr2022 till 24May2022 for the treatment of COVID-19. Started feeling better within a day. Cough was gone, still very fatigued. Followed CDC guidelines. On 24Apr she did a rapid test and was negative. Still fatigued but no other symptoms. On 28Apr2022, she woke up with extreme nasal congestion, watering eyes, sneezing, and slight headache. She did a home test and it was a strong positive. She had a PCR on 31Apr2022 that confirmed positive. Patient did not have other medical history. She did not know that she had known allergy. Patient received Zyertec medication in 2weeks and Prednisone from 12May2022 to 16May2022.
Nine days after booster I developed some hives. The next day the hives spread across my body. My skin is extremely sensitive and if itched the hives appear 10-15 mins later. On the 22nd I began experiencing joint pain along with the hives. On the 23rd the joint pain increases and the hives still occur.
The moment the nurse injected me, I felt burning down my entire arm and a deep ache. The next morning, I woke up, and the lymph nodes in my neck, clavicle, and under my arms on both sides. I had extreme pain all the way down my spine and was unable to get out of bed for a few days. I messaged my doctor and he offered steroids which I declined because of my chronic conditions. This lasted 2 weeks. Once the lymph nodes finally went down, I was left with pain in the arm and shoulder where I received the injection. Since that time I have lost the range of motion in my shoulder and have seen my Ortho on June 21, 2021 and received a Cortisone shot to help the inflammation to no avail.  I am still unable to move my arm without extreme pain
Patient reports vomiting, diarrhea, muscle aches, fatigue within 12 hours of vaccination.
Presented with gradual onset of anterior chest pain that started approximately 30 minutes to 1 hour after receiving the H1N1 nasal mist vaccine this morning.  She was feeling well prior and during her vaccination. She returned to work and shortly after developed chest pain at her desk.The pain persisted so she called employee health and was instructed to go to ED.
fever of 39C; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): MDIT22-00132 (Moderna).  A 28 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in deltoid right, administration date 14Aug2021 (Lot number: FG4686) at the age of 28 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Administered into the left deltoid muscle. Batch: FE2707.), administration date: 07May2021, when the patient was 28 years old, for Covid-19 Immunization, reaction(s): "moderate muscle pain", "joint pain", "pain and swelling focused at the injection site", "pain and swelling focused at the injection site". The following information was reported: PYREXIA (non-serious) with onset Aug2021, outcome "unknown", described as "fever of 39C". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia.  Additional information:   No follow-up attempts are possible. No further information is expected.
Chills; fever of 102°F; This spontaneous case was reported by a non-health professional and describes the occurrence of CHILLS (Chills) and PYREXIA (fever of 102°F) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced CHILLS (Chills) and PYREXIA (fever of 102°F). At the time of the report, CHILLS (Chills) and PYREXIA (fever of 102°F) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medication reported  No treatment information was provided
In the afternoon he started having a low grade temp what I know is normal. I gave him 0.4 mL of Infant Tylenol at around 4 PM. Later on that evening he started to be more fussy. At around 11:30 PM he suddenly projectile vomitited. He fell asleep soon after that. The next morning on 12/03 he ate some breakfast and while I was holding him he again suddenly projectile vomited all over. That was more than I've ever seen. He also had a temp of 102 most of the day. In the evening I took him to the ER and they sent us back home after some observation. That night he seemed to not be able to breathe right and choke on himself. He was sleepy and just not as happy as usual.
Pt recvd vax & 10 days later exp red area, induration & fluid-filled blister @ inject site; Reporter indicates site is healed but has a scar the size of the fluid filled blister that was there.
approx 1/2 hr post vax pt exp flushing all over body, extreme itching & hives on legs; pt stated lips felt itchy;DPH given;BP 142/94, pulse 80;pt went to ER;
Patient is a 63 y.o. male patient of MD with PMH of Afib, COPD with chronic respiratory failure, CHF, Cocaine use, pulm HTN presented to the ED due to SOB.     Acute on chronic hypoxemic and hypercarbic respiratory failure- Secondary to COVID, COPD, Afib RVR On 2-3L NC at home, escalated to nasal oxymizer Lasix initiated 11/11 Transition to nasal cannula and weaned to home 3 L 11/13 Stable for home discharge   Covid-19 Virus Infection Date of onset of symptoms: 11/6 Symptoms present on admission: Cough, SOB, myalgias. Date of covid positive test: 11/9/2022 Vaccination status: vaccinated Imaging: CXR with Patchy airspace disease noted bilaterally, suspicious for multifocal pneumonia given the clinical history. CTPA with no PE, Patchy airspace disease noted within the mid to lower lung zones bilaterally, left greater than right,  suggesting atelectasis or early pneumonia. Oxygen requirements on admission: 6L Current oxygen requirements: 3 L nasal cannula Medical therapy: Completed remdesivir 11/13, continue steroids 10 days, s/p rocephin, and Zithromax  Consultants following: Pulm consulted Anticipated special isolation end date: 11/16 BC negative Discharge on 5 more days of decadron   Acute exacerbation of COPD On scheduled and prn bronchodilators Azithromycinx 5 days , decadron. Resume home symbicort, spiriva. Continue home daliresp.  Pulm consulted, Weaning oxygen to home O2   Atrial fibrillation with RVR Troponin 29, repeat 29 -due to arrhythmia On Cardizem gtt-weaned off 11/13 on Cardizem CD increased to 180 mg daily 11/13 Resume aspiriAtrial fibrillation with RVR Troponin 29, repeat 29 -due to arrhythmia On Cardizem gtt-weaned off 11/13 on Cardizem CD increased to 180 mg daily 11/13 Resume aspirin 81 mg at home and no anticoagulation, with CHA2Ds2vasc1   Hyperglycemia Presume secondary to steroids use A1c was 6 on 9/22 Blood glucose >240 Start Lantus 10 units and sliding scale/prandial insulin Do not anticipate he will need for discharge home Patient refuses despite significant education Agreeable to a regular diet as long as we can treat her hyperglycemia   Substance use disorder UDS with cocaine and fentanyl. Will reassess for willingness to discuss with addiction medicine No current symptoms of withdrawal   Pulmonary hypertension  Related to COPD, drug use and chronic respiratory failure with hypoxemia Echo 1/2022 showed TR velocity 3.66   Chronic HFpEF Not in exacerbation TTE 60% Continue monitoring on ASA, diltiazemn 81 mg at home and no anticoagulation, with CHA2Ds2vasc1
Chest pain, side stomach pain and back pain. It feels like a nerve pain that started off on the lower left side of my torso.
I had serve stomach cramps and diarrhea.  I had a tv conference with my doctor.  He prescribed me some medicine for it.  It went away and then came back. I lost 20 lbs.  I went to see a GI doctor on August 11th.  They did blood work and stool sample, normal result.  I had a coloscopy on Sept. 23rd.  It came back normal.  He diagnosed me with Bile acid malabsorption (BAM).  He prescribed me more medicine which I did not take because after the coloscopy.  It went away.
Appx one week after vaccine, injection site became red, swollen, tender to touch and arm started to ache. The pain started to get progressively worse.
sick; Initial information was received on 06-Dec-2020 regarding an unsolicited valid non-serious case from a consumer (patient) via social media.  This case involves a patient of unknown demographics who was currently 65 years old, who had been sick (illness), while patient had received INFLUENZA VACCINE.  Medical history included being sick a few times.  Information about vaccination(s), medical treatment(s), family history and concomitant medication were unknown.  On an unknown date, the patient received influenza vaccine [lot number: unknown and expiration date: unknown] at an unknown dose via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, (latency: unknown) after being vaccinated with INFLUENZA VACCINE, patient was sick (illness). The patient also reported that all the previous sickness were less severe in comparison to the sickness post vaccination and that the patient did not receive flu shots since high school.   No laboratory data was reported.  It was not reported if the patient received any corrective treatment. However, the patient had reported about strengthening the immune system by consuming Vitamins and herbs.   At the time of reporting, outcome of the events was unknown.  There will be no information available regarding batch number in this case.
Came to clinic just for flu vaccination, after receiving vaccine patient fainted while walking out to car, dad caught patient. Pt sweaty and light headed for about 10 mins, gave juice and crackers. Vitals stable. Felt better after 10 min, no additional tx needed.
This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Two patients received a booster dose of Moderna Covid-19 vaccine on day 32 of being in the refrigerator) and PRODUCT STORAGE ERROR (Two patients received a booster dose of Moderna Covid-19 vaccine on day 32 of being in the refrigerator) in a 38-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 18-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Two patients received a booster dose of Moderna Covid-19 vaccine on day 32 of being in the refrigerator) and PRODUCT STORAGE ERROR (Two patients received a booster dose of Moderna Covid-19 vaccine on day 32 of being in the refrigerator). On 18-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Two patients received a booster dose of Moderna Covid-19 vaccine on day 32 of being in the refrigerator) and PRODUCT STORAGE ERROR (Two patients received a booster dose of Moderna Covid-19 vaccine on day 32 of being in the refrigerator) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not provided.   This case was linked to MOD-2022-456292 (Patient Link).
DIAGNOSIS: Hypoxia, COVID, pneumonia -Onset date: 2/4 -presented with fevers, dry cough in ED -vaccinated x 2 with booster -initial dimer 2.14 -Admit to RCU: contact/airborne precautions -Covid test date: 2/6 + by Abbott -CTA negative -remdesivir/ dexamethasone 2/6-2/8 -titrate O2 92-94% on room air and with activity -Ambulatory O2 challenge twice daily, once per shift -incentive spirometry  -isolate for 20 days 2/4/22-2/24/22
Patient reported having an allergic reaction to flu vaccine in the past. Symptoms included swelling and itching in the arm the vaccine was  injected. Patient given Benadryl for similar symptoms. Patient was observed for 30 minutes with no signs of airway or circulation issues. Patient is to report to her Primary Care Physician for any other issues.
Nausea; Chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NAUSEA (non-serious), outcome "unknown", described as "Nausea"; CHILLS (non-serious), outcome "unknown", described as "Chills".  Additional information: Follow-up attempts are completed. No further information is expected.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.